Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The TREX Trial
NCT03089905Phase 3Active, not recruiting
- Sponsor
- Murdoch Children's Research Institute
- Start
- Aug 2017
- Primary completion
- Oct 2026
- Modality
- Orthosteric Ligands
- Countries
- 4
01
Overview
A Phase 3 trial of sevoflurane, dexmedetomidine, remifentanil, sponsored by Murdoch Children's Research Institute. Started Aug 2017; status: active, not recruiting.
02
Drugs
sevofluranedexmedetomidineremifentanil
Beyond the preview
Go deeper on NCT03089905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03089905.